Health: Migraines

Baroness Blackwood of North Oxford Excerpts

Tuesday 24th October 2023 Lords Chamber

[Viscount Younger of Leckie (Con)]

I will certainly reflect upon that and take it away, but I have given some idea as to the work we are doing with employers and—I say again—it is an incredibly important issue for all employers, particularly small businesses. There are 5.4 million or so of those in this country, for which there is little access to occupational health—something I could talk about another time—where advice needed for employees who suffer is better given.

[Baroness Blackwood of North Oxford (Con)]

My Lords, I declare my interest. I have had well-controlled chronic migraine, which was not managed until I was able to access a specialist. It was welcome that NICE recently approved a new drug for acute migraine and noted that the condition affects every aspect of life. Currently, when triptan is ineffective, there is no further standard treatment and people are advised to see a specialist. However, there is a significant shortage of access to those specialists and long waiting lists. I return to the question from the other side of the Chamber. What can we do to improve access to those specialists, get more migraines under control and those people back into the workplace? What would the Minister’s response be to the provision of something like migraine hubs such as those we have for musculoskeletal conditions?

[Viscount Younger of Leckie (Con)]

Indeed. Just to echo what my noble friend said, as she will know, migraine treatments include painkillers such as ibruprofen and paracetamol, medicines called triptans, to which she referred, and medicines including anti-emetics which stop one feeling sick. More than that, I allude to the NHS national workforce plan, whereby we have a long-term vision for the training required and individuals that we need to help deal with this difficult affliction.